Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 2/2024

Open Access 26-12-2023 | Iron Deficiency | Research Article

Management of iron deficiency in women of childbearing age with oral iron intolerance: a prospective, randomised, controlled trial of three doses of an iron-whey-protein formulation

Prospective RandomisEd study of women of Childbearing age with gastroInteStinal Intolerance to Oral iroN (PRECISION)

Authors: Mark Ledwidge, Fiona Ryan, Anna Seoighe, Maria Jose Santos-Martinez, Cristin Ryan, J. G. F. Gilmer

Published in: International Journal of Clinical Pharmacy | Issue 2/2024

Login to get access

Abstract

Background

Nutritional deficit and oral iron gastrointestinal intolerance may be a common cause of iron deficiency, which can be managed by pharmacists.

Aim

To understand the prevalence of iron deficiency in women of childbearing age with a self-reported history of intolerance to oral iron and the tolerability of three doses of an iron-whey-protein formulation in the care of these women.

Method

Ferritin and haemoglobin levels were documented in women of childbearing age with oral iron gastrointestinal intolerance. In those with iron deficiency (ferritin < 30 µg/L), adherence, gastrointestinal tolerability, ferritin, transferrin saturation and haemoglobin levels were compared between their prior oral iron product and iron-whey-protein microspheres randomised to three doses (14 mg daily, 25 mg daily and 50 mg daily) for 12 weeks.

Results

Most screened women had low iron stores (128 (62.7%); ferritin < 30 µg/L), 65 (31.9%) had moderate to severe iron deficiency (ferritin < 12 µg/L) and 33 (16.2%) had iron deficiency anaemia (ferritin < 30 µg/L, haemoglobin < 12 g/dL). Amongst the 59 women who participated in the prospective clinical study of iron-whey-protein microspheres over 12 weeks, 48 (81.4%) were classified as adherent/persistent and fewer instances of gastrointestinal intolerance were reported (0.59 ± 0.91) when compared to 12 (20.3%) and (4.0 ± 2.2) respectively while taking the prior oral iron (Fisher’s Exact and T-test respectively, both p < 0.001). There was no difference in adherence or tolerability of different iron-whey-protein formulation doses. Ferritin, haemoglobin and energy levels increased significantly over 12 weeks.

Conclusion

Undiagnosed iron deficiency is common in women of childbearing age with a history of intolerance to oral iron and iron-whey-protein microspheres can improve adherence, GI tolerability, iron stores, haemoglobin and energy levels in these women.

Clinical trial registration

Clinicaltrials.gov identifier (registration includes full trial protocol): NCT04778072.
Appendix
Available only for authorised users
Literature
1.
go back to reference Guideline: daily iron supplementation in adult women and adolescent girls. Geneva: World Health Organization; 2016. Guideline: daily iron supplementation in adult women and adolescent girls. Geneva: World Health Organization; 2016.
2.
go back to reference Guideline: Iron supplementation in postpartum women. Geneva: World Health Organization; 2016 Guideline: Iron supplementation in postpartum women. Geneva: World Health Organization; 2016
3.
15.
19.
go back to reference Walker S, Paton T, Cowan D, et al. Bioavailability of iron in oral ferrous sulfate preparations in healthy volunteers. Can Med Assoc J. 1989;141:543–7. Walker S, Paton T, Cowan D, et al. Bioavailability of iron in oral ferrous sulfate preparations in healthy volunteers. Can Med Assoc J. 1989;141:543–7.
22.
go back to reference Kulich KR, Madisch A, Pacini F, et al. Reliability and validity of the gastrointestinal symptom rating scale (GSRS) and quality of life in reflux and dyspepsia (QOLRAD) questionnaire in dyspepsia: a six-country study. Health Qual Life Outcomes. 2008;6:1–2. https://doi.org/10.1186/1477-7525-6-12.CrossRef Kulich KR, Madisch A, Pacini F, et al. Reliability and validity of the gastrointestinal symptom rating scale (GSRS) and quality of life in reflux and dyspepsia (QOLRAD) questionnaire in dyspepsia: a six-country study. Health Qual Life Outcomes. 2008;6:1–2. https://​doi.​org/​10.​1186/​1477-7525-6-12.CrossRef
Metadata
Title
Management of iron deficiency in women of childbearing age with oral iron intolerance: a prospective, randomised, controlled trial of three doses of an iron-whey-protein formulation
Prospective RandomisEd study of women of Childbearing age with gastroInteStinal Intolerance to Oral iroN (PRECISION)
Authors
Mark Ledwidge
Fiona Ryan
Anna Seoighe
Maria Jose Santos-Martinez
Cristin Ryan
J. G. F. Gilmer
Publication date
26-12-2023
Publisher
Springer International Publishing
Keyword
Iron Deficiency
Published in
International Journal of Clinical Pharmacy / Issue 2/2024
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-023-01640-7

Other articles of this Issue 2/2024

International Journal of Clinical Pharmacy 2/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine